Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada
Abstract Background Every year, over 1 million people develop isoniazid (INH) resistant tuberculosis (TB). Yet, the optimal treatment regimen remains unclear. Given increasing prevalence, the clinical efficacy of regimens used by physicians is of interest. This study aims to examine treatment outcom...
שמור ב:
| Principais autores: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2017-09-01
|
| סדרה: | BMC Infectious Diseases |
| נושאים: | |
| גישה מקוונת: | http://link.springer.com/article/10.1186/s12879-017-2706-0 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
